Chronix Biomedical, Inc.
$4.2M
Chronix is a molecular diagnostics company that develops DNA-based blood tests to detect, monitor and manage tumors.
Insight Genetics, Inc.
$12M
Insight is a molecular diagnostic company that discovers, develops and commercializes therapies for the treatment of cancer.
Razor Genomics, Inc.
$10M
Razor Genomics is a life science company that researches and develops novel tests for the diagnosis of early-stage lung cancer.